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Rickettsia felis  




To the Editor: Fleaborne disease 
is highly prevalent in Laos, mainly at-
tributed to murine typhus (Rickettsia 
typhi infection), transmitted by Xeno-
psylla cheopis fleas, but data on other 
fleaborne diseases are limited (1). We 
screened blood and cerebrospinal fluid 
(CSF) from participants in 2 large pro-
spective studies in Laos for Rickettsia 
spp. using a genus-specific 17-kDa–
based Rickettsia real-time quantita-
tive PCR assay, and positive results 
were confirmed by DNA sequencing 
(2,3). In samples from >2,500 patients 
(2,540 blood and 1,112 CSF), we 
detected 3 cases of sequence-con-
firmed R. felis infections.
A 50-year-old man, an official in 
Vientiane City, was admitted to a hospi-
tal with fever and headache in October, 
2008. HIV infection and cryptococcal 
meningitis were diagnosed. Treatment 
with intravenous amphotericin B, then 
oral fluconazole, was successful; an-
tiretroviral treatment was initiated 1 
month after diagnosis. Among a panel 
of diagnostic PCRs, the CSF sample 
specimen tested positive for genus-
specific 17-kDa–Rickettsia quantitative 
PCR, but was negative for Orientia 
tsutsugamushi and R. typhi. DNA se-
quencing of 434 bp of the 17-kDa gene 
(Macrogen, Seoul, South Korea) re-
vealed a 100% homology to the R. felis 
URRWXCal2 strain (Table).
R. felis positivity in CSF is rare; 
4 cases have been reported (3). The 
combined findings of R. felis infec-
tion and severe immunodeficiency in 
this patient led to a reevaluation of the 
2 reported R. felis infections in Laos 
(2). Before this study, R. felis DNA or 
culture had not been handled in our fa-
cility. The interval between processing 
positive samples, dedicated separate ar-
eas for samples before and after PCR, 
and the low positivity rate make DNA 
contamination highly unlikely.
A 39-year-old housewife from 
Luang Namtha in northern Laos had 
a history of diabetes mellitus, which 
had been treated with glibenclamide. 
On arrival at the hospital in Novem-
ber, 2008, she had fever, headache, 
myalgia, and an eschar. She was em-
pirically treated with doxycycline 
(Table). An eschar biopsy specimen 
was PCR-positive for Rickettsia spp. 
and O. tsutsugamushi; PCR of buffy 
coat detected O. tsutsugamushi DNA 
only (2). Molecular characterization 
included 17-kDa and sca4 gene se-
quencing, which both revealed ampli-
cons of 100% identity to the R. felis 
URRWXCal2 strain. Serologic evi-
dence for O. tsutsugamushi infection 
(scrub typhus) included a 4-fold rise in 
IgM and IgG titers, and IgM and IgG 
titers against typhus group rickettsiae, 
spotted fever group rickettsiae, and 
R. felis (isolate B377 in XTC-2 cells, 
Australian Rickettsial Reference Lab-
oratory) were negative in admission 
and convalescent-phase samples (6-
day interval) (Table).
A 13-year-old boy from Salavan, 
in southern Laos, had fever, head-
ache, and nonspecific symptoms in 
July, 2009. P. falciparum malaria and 
dengue were diagnosed, both con-
firmed by PCR (Table). PCR results 
for the buffy coat specimen were 
positive for the 17-kDa gene; subse-
quent sequencing confirmed R. felis 
with 100% identity to the URRWX-
Cal2 strain. The fever resolved after 
treatment with antimalarial drugs 
and ceftriaxone; neither would be 
expected to be efficacious for R. 
felis infection.
These data suggest that R. felis oc-
curs in Laos, and is possibly emerging, 
but whether it results in clinical disease 
or commonly causes subclinical infec-
tion is unknown. The screened cohorts 
of consecutively enrolled patients with 
febrile illnesses across 3 diverse geo-
graphic regions are representative of 
etiologic agents of fever across Laos. 
PCR has previously been used for de-
tection of R. felis and resulted in the 
discovery of a new R. felis–like organ-
ism in fleas in Kenya, Candidatus Rick-
ettsia asemboensis (4). Reports from 
Southeast Asia suggest that R. felis is 
not a common cause of febrile illness 
(1,2), which contrasts with findings 
in Kenya, where R. felis was found in 
≈7% of febrile patients (4,5), and also 
in ≈3% of afebrile patients (5).
The high R. felis carriage rate in 
fleas found in Laos (77% overall; 53% 
in Ctenocephalides felis felis, 89% in 
C. f. orientis) contrasts strongly with 
the apparent low incidence of R. felis 
human infections (6). Among febrile 
hospitalized patients in Vientiane, 
1 case of R. felis infection was sero-
logically diagnosed by using species-
specific cross-absorption (1). Sero-
prevalence studies in the region could 
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elucidate exposure to this pathogen 
and unmask subclinical infections 
missed in fever etiology studies.
The 3 patients from Laos de-
scribed herein had comorbidities as-
sociated with variable degrees of im-
munodeficiency (HIV infection and 
malaria with cellular and humoral 
deficiencies, diabetes with functional 
neutrophil/macrophage impairment) 
(7,8). R. felis infections have not been 
associated with immunosuppression, 
but few investigations of this pos-
sible association have been published. 
Of the 3 patients, the woman and the 
boy had other vectorborne infections: 
scrub typhus, transmitted by Lep-
totrombidium mites, and P. falciparum 
malaria and dengue, transmitted by 
Anopheles and Aedes mosquitoes, re-
spectively. Recent reports described 
R. felis within a great diversity of 
vectors, including mites in South Ko-
rea and Anopheles and Aedes mosqui-
toes in Africa (9,10).
More work is needed on the role of 
non-flea vectors in transmission of R. fe-
lis and the consequences this may have 
in terms of mixed infections of diverse 
vectorborne pathogens. The rare detec-
tion of R. felis in patients, combined 
with high flea carriage rates, unusual 
signs and symptoms linked to immuno-
deficiencies or multiple infections, and 
reports from Africa describing R. felis 
in asymptomatic patients, underscore 
the need for further investigations into 
the organism’s natural history and its 
uncertain role as a pathogen.
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Chikungunya  
Outbreak in Bueng 
Kan Province,  
Thailand, 2013
To the Editor: Chikungunya fe-
ver is a dengue-like syndrome charac-
terized by acute fever, arthralgia, and 
maculopapular rash. The causative 
agent is chikungunya virus (CHIKV), 
which is transmitted by Aedes aegypti 
and Aedes albopictus mosquitoes (1). 
Based on the genome and the viral en-
velope E1 sequences, CHIKV is clas-
sified into 3 genetic lineages: Asian, 
West African, and East/Central/South 
African (ECSA) genotypes (2).
In Thailand, the first report of 
CHIKV infection occurred in Bang-
kok in 1958 (3); later, sporadic cases 
of chikungunya fever occurred in 
many provinces during 1976–1995 
(4). All of the CHIKV strains found 
in Thailand at that time were of the 
Asian genotype. The virus has since 
reemerged during 2008–2009 and 
caused large outbreaks in southern 
Thailand, affecting >50,000 persons 
(5). These outbreaks were attributed 
to the ECSA genotype. We report an 
outbreak of CHIKV infection in the 
northeastern province of Bueng Kan 
in 2013.
Bueng Kan Province is located 
on the Mekong River on the foothills 
of the mountainous region of Laos to 
the north. An outbreak of suspected 
dengue cases was reported during the 
rainy season during April–September 
2013(6). Beginning in September, 
however, hospital physicians noticed 
that patients were reporting fever with 
moderate to severe joint pain result-
ing in limitation of movement that 
lasted for weeks. Serum samples were 
collected from 109 persons (hospital-
ized and outpatient) in October. Clini-
cal data showed that 38 (34.9%) had 
moderate to severe joint pain; median 
duration of illness was 4 days (range 
1–7). Median timing of sample col-
lection from the onset of illness was 8 
days (range 1–21).
Samples were sent to Chulalong-
korn University Hospital in Bangkok 
to screen for mosquitoborne viruses. 
The study protocol was approved by 
the Institutional Review Board of Ch-
ulalongkorn University and consents 
were waived because all samples were 
stored as anonymous. Viral genomic 
RNA was assayed by using semin-
ested reverse transcription PCR (RT-
PCR) for CHIKV nucleic acid (7). 
Serum samples were tested for IgM 
against  CHIKV by using SD BIO-
LINE Chikungunya IgM Test (Stan-
dard Diagnostics Inc., Kyonggi-do, 
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